USPTO 2015–2025 USPTO PatentsView US Corporation

Optimist Inhaler, LLC

USPTO PatentsView assignee record - 6 granted patents across 3 technology areas, recorded in grant years 2019–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Optimist ranks #42,137 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 3 technology areas.

#42,137
of 49,997 US assignees by volume
3rd percentile
by Innovation Score (15.3/100)
4.2
avg claims per patent
-80%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R42137 · US Corporation #42,137 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-SPARSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 6 grants
  • LOWER-Q #42,137/49,997
  • PHOTO-FINISH Optical Fusion
  • CPC-NARROW A61B · 3 areas
  • INNOV-LOW 15.3/100
  • CLAIMS-SPARSE 4.2 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -80% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Optical Fusion, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Optimist’s 15.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Optimist

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Optimist's Innovation Score is 15.3/100 (3rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Optimist?

Each dot is one of Optimist’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Optimist’s own 4.2 claims/patent is at or below the 15.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Optimist vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 5.96.06.066.06.06.1 0510152025 Granted patents (volume) Avg claims / patent Optical Fusion, Inc. - 6, 16.17Optical FusionOpticon Sensors Europe B.V. - 6, 14Opticon Sensors E…OptimERA Holdings, Inc. - 6, 22.17Optimera HoldingsOptimark, L.L.C. - 6, 17Optimark L L COptimus Technologies, Inc. - 6, 16.5OptimusOpto Electronics Solutions - 6, 13.67Opto SolutionsOptoskand AB - 6, 15.5Optoskand ABOpus KSD Inc. - 6, 12.67Opus KSDOptimist Inhaler, LLC - 6, 4.17Optimist Inhaler
Optimist vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Optimist's grants concentrate

Optimist Inhaler, LLC is a focused PatentsView assignee: 3 CPC subclasses with 16.7% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2019 (5 grants) versus a trough of 1 in 2020. By volume, Optimist sits between Optical Fusion, Inc. and Opus KSD Inc..

Who files at Optimist's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Optimist holds 6 patents at rank #42,147, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Optimist

By rank, the assignees closest to #42,147 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Optimist's primary technology class.

Optimist's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

15 3rd percentile higher than 3% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 20192020 1
USPTO utility patent grants by year · 2019–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table
Optimist Inhaler, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2019 5 83.3%
2020 1 16.7%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Optimist Inhaler, LLC's patent record in context - here's where to go next.

  • Optimist Inhaler, LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 16.7% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #42,137 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Optimist Inhaler, LLC against Optical Fusion, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 15.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.